Lung Biotechnology operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, specializing in innovative therapies to address severe pulmonary conditions. The company is dedicated to enhancing the quality of life for patients through advanced biotechnology solutions that target critical medical needs in respiratory health.
Specialties
Innovative pulmonary therapies
Advanced biotechnology solutions
Severe respiratory condition treatment
Chronic illness management
Patient quality of life enhancement
Products & Services
Pulmonary Arterial Hypertension Treatments
Organ Replacement Therapies
Pulmonary Disease Management
Transplantation Innovations
Research and Development Services
Contact Information
No contact information available
Competitors & Similar Companies(10)
Vertex Pharmaceuticals
Massachusetts, • United States
Gilead Sciences
California, • United States
Boehringer Ingelheim
Rheinland-Pfalz, • Germany
AstraZeneca
Greater London, • United Kingdom
Regeneron Pharmaceuticals
New York, • United States
Novartis
Basel-City, • Switzerland
Amgen
California, • United States
Sanofi
Île-De-France, • France
Roche
Basel-City, • Switzerland
Pfizer
New York, • United States
News & Media
Search Terms:
lung biotechnology
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Lung Biotechnology belongs to the Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Lung Biotechnology?
Lung Biotechnology specializes in Innovative pulmonary therapies, Advanced biotechnology solutions, Severe respiratory condition treatment, Chronic illness management, Patient quality of life enhancement.
What products and services is Lung Biotechnology likely to offer?
Lung Biotechnology offers Pulmonary Arterial Hypertension Treatments, Organ Replacement Therapies, Pulmonary Disease Management, Transplantation Innovations, Research and Development Services.
Who are the competitors of Lung Biotechnology?
Competitors of Lung Biotechnology are Vertex Pharmaceuticals, Gilead Sciences, Boehringer Ingelheim, AstraZeneca, Regeneron Pharmaceuticals, Novartis, Amgen, Sanofi, Roche, Pfizer.
What does Lung Biotechnology do?
Lung Biotechnology operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, specializing in innovative therapies to address severe pulmonary conditions. The company is dedicated to enhancing the quality of life for patients through advanced biotechnology solutions that target critical medical needs in respiratory health.
What are the social media links of Lung Biotechnology?
Social media links of Lung Biotechnology areLinkedIn